MTM Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.8M Sell
9,034
-5
-0.1% -$5.11K 3.09% 3
2026
Q1
$8.31M Sell
9,039
-15
-0.2% -$15.2K 2.63% 6
2025
Q4
$9.73M Sell
9,054
-602
-6% -$576K 3.11% 4
2025
Q3
$7.37M Buy
9,656
+1
+0% +$744 2.34% 9
2025
Q2
$7.53M Hold
9,655
2.53% 7
2025
Q1
$7.77M Sell
9,655
-9
-0.1% -$7.49K 3.01% 3
2024
Q4
$7.46M Hold
9,664
2.87% 5
2024
Q3
$8.57M Sell
9,664
-1,130
-10% -$1.02M 3.34% 3
2024
Q2
$9.77M Sell
10,794
-249
-2% -$199K 4% 3
2024
Q1
$8.59M Buy
11,043
+43
+0.4% +$30.6K 3.54% 3
2023
Q4
$6.41M Buy
11,000
+1
+0% +$584 2.93% 4
2023
Q3
$5.91M Sell
10,999
-25
-0.2% -$12.9K 2.98% 4
2023
Q2
$5.17M Buy
11,024
+1
+0% +$419 2.52% 4
2023
Q1
$3.79M Buy
11,023
+1
+0% +$337 1.94% 9
2022
Q4
$4.03M Buy
11,022
+1
+0% +$355 2.09% 9
2022
Q3
$3.56M Buy
11,021
+1
+0% +$317 2.02% 8
2022
Q2
$3.58M Buy
11,020
+35
+0.3% +$10.5K 1.93% 9
2022
Q1
$3.15M Buy
10,985
+127
+1% +$32.7K 1.52% 13
2021
Q4
$3M Sell
10,858
-29
-0.3% -$7.35K 1.43% 15
2021
Q3
$2.52M Sell
10,887
-3,069
-22% -$757K 1.37% 16
2021
Q2
$3.2M Hold
13,956
1.68% 9
2021
Q1
$2.61M Buy
13,956
+1
+0% +$196 1.47% 16
2020
Q4
$2.36M Buy
+13,955
New +$2.08M 1.46% 15

Other funds holding LLY

MTM Investment Management's LLY Position: Q2 2026 in Review

MTM Investment Management reduced its Eli Lilly (LLY) stake by 0.06% in Q2 2026, selling an estimated $5.11K and leaving 9,034 shares worth $10.8M. The position accounts for 3.09% of the portfolio, ranked #3.

MTM Investment Management first reported a position in LLY in Q4 2020 and has held it in 23 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • MTM Investment Management held 9,034 shares of Eli Lilly worth $10.8M as of Q2 2026.
  • MTM Investment Management sold 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
  • Eli Lilly made up 3.09% of MTM Investment Management's portfolio in Q2 2026, its #3 holding.
  • MTM Investment Management first reported a position in Eli Lilly in Q4 2020 and has held it in 23 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on MTM Investment Management's 13F filing for Q2 2026, filed 3 Aug 2026.